DalsnaFinance › IPOs › Sionna Therapeutics Inc › IPO
Sionna Therapeutics, Inc. completed its initial public offering on NASDAQ on February 7, 2025, pricing at $18.00 a share.
| Ticker | SION |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | February 7, 2025 |
| Offering price | $18.00 |
| Shares offered | 10,588,233 |
| Total raised | $191M |
Sionna Therapeutics, Inc. sold 10,588,233 shares at $18.00 each on NASDAQ. Multiplied out, that is $190.6 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $191 million total recorded for the deal.
Measured by money raised, Sionna Therapeutics, Inc. was tied for the 244th largest (level with 1 other deal) of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million.
Among the 342 listings on NASDAQ alone, it is tied for the 176th largest (level with 1 other listing).
February 2025 saw 20 completed IPOs in the site's data; by amount raised, Sionna Therapeutics, Inc. was the 10th largest of the 20 deals with a recorded size.
Its $18.00 offer price was tied for the 82nd highest (level with 12 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
Sionna Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Sionna Therapeutics, Inc.. This page is general information, not investment advice.